Receipt of anti-SARS-CoV-2 pharmacotherapies among U.S. Veterans with mild to moderate COVID-19, January-February 2022

Kristina L. Bajema, Xiao Qing Wang, Denise M. Hynes, Mazhgan Rowneki, Alex Hickok, Francesca Cunningham, Amy Bohnert, Edward J. Boyko, Theodore J. Iwashyna, Matthew L. Maciejewski, Elizabeth M. Viglianti, Elani Streja, Lei Yan, Mihaela Aslan, Grant D. Huang, George N. Ioannou
doi: https://doi.org/10.1101/2022.06.22.22276782

Data Availability

All data produced in the present work are contained in the manuscript

Back to top
Posted June 23, 2022.
Download PDF
Data/Code
Email
Receipt of anti-SARS-CoV-2 pharmacotherapies among U.S. Veterans with mild to moderate COVID-19, January-February 2022
Kristina L. Bajema, Xiao Qing Wang, Denise M. Hynes, Mazhgan Rowneki, Alex Hickok, Francesca Cunningham, Amy Bohnert, Edward J. Boyko, Theodore J. Iwashyna, Matthew L. Maciejewski, Elizabeth M. Viglianti, Elani Streja, Lei Yan, Mihaela Aslan, Grant D. Huang, George N. Ioannou
medRxiv 2022.06.22.22276782; doi: https://doi.org/10.1101/2022.06.22.22276782
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area